Hodess

About Hodess

A Other / Uncategorized player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• BioPharma Reporter · 2026-06-15
  Hodess publishes dosimetry data at SNMMI 2026
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• FierceBiotech · 2026-01-08
  Hodess closes Series C round to scale radiopharma manufacturing
  The work builds on more than a decade of radiochemistry collaboration.
• Endpoints News · 2026-12-21
  Hodess partners with academic center on Actinium-225 program
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Reuters Health · 2026-07-22
  Hodess files IND for next-generation PSMA-targeted agent
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• PR Newswire · 2026-10-03
  Hodess announces Phase II readout for lead theranostic candidate
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.